Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | USP2 | O75604 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.77 |
| ▸ | DHCR24 | Q15392 | 11/20 | 0.77 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5823900 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL6900565 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL1237838 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL22318602 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL599029 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL30897555 | 1.00 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL28186368 | 0.94 | MEN1 (0.85) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL14911153 | 0.89 | ALDH1A1 (0.80) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL15346215 | 0.89 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL4625070 | 0.89 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7863470-B2 | Linear polyethylenimine-sterol conjugates for gene delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-01-04 | — | — | US | claimed |
| US-20070154447-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | FURGESON DARIN Y | 2007-07-05 | — | — | US | claimed |
| US-7183263-B2 | Linear polyethylenimine-sterol conjugates for gene delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-02-27 | — | — | US | claimed |
| US-20040137050-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2004-07-15 | — | — | US | claimed |
| EP-4731009-A1 | LINSEED OIL PRODUCTION SYSTEM, LINSEED OIL PRODUCTION PROCESS AND LINSEED OIL | LIN DES PYRÉNÉES (FR) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024235681-A1 | LINSEED OIL PRODUCTION SYSTEM, LINSEED OIL PRODUCTION PROCESS AND LINSEED OIL | Lin des Pyrénées (FR) | 2024-11-21 | — | — | WO | disclosed |
| US-11918770-B2 | Implants for localized drug delivery and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-03-05 | — | — | US | disclosed |
| CN-114159480-B | Composition with weight-losing effect and preparation method and application thereof | 夏文华 | 2022-08-30 | — | — | CN | disclosed |
| US-20220184362-A1 | Implants for Localized Drug Delivery and Methods of Use Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-16 | — | — | US | disclosed |
| US-11324935-B2 | Implants for localized drug delivery and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-10 | — | — | US | disclosed |
| CN-114159480-A | Composition with weight-losing effect and preparation method and application thereof | 广州臻卓生物技术有限公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-3833737-A1 | GENETICALLY-MODIFIED BACTERIA AND USES THEREOF | Cambrex Karlskoga AB (SE) | 2021-06-16 | — | — | EP | disclosed |
| US-20080181928-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES FOR LIPOSOME DELIVERY | MIV THERAPEUTICS, INC. (CA) | 2008-07-31 | — | — | US | disclosed |
| WO-2008077247-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES COMPRISING CHOLESTEROL | MIV THERAPEUTICS INC. (CA) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008077248-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES FOR LIPOSOME DELIVERY | MIV THERAPEUTICS INC. (CA) | 2008-07-03 | — | — | WO | disclosed |
| US-20070254859-A1 | Compounds exhibiting efflux inhibitor activity and composition and uses thereof | EASTMAN CHEMICAL COMPANY | 2007-11-01 | — | — | US | disclosed |
| US-20070154447-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | FURGESON DARIN Y | 2007-07-05 | — | — | US | disclosed |
| CN-1993126-A | Use of a steroid for enhancement of skin permeability | NOVARTIS AG (CH) | 2007-07-04 | — | — | CN | disclosed |
| US-7183263-B2 | Linear polyethylenimine-sterol conjugates for gene delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-02-27 | — | — | US | disclosed |
| US-20040137050-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254859-A1 | Compounds exhibiting efflux inhibitor activity and composition and uses thereof | ABCC4, NCOA4, NR4A3 | ALDH1A1 2000/4885MEN1 4281/4885KMT2A 4362/4885 |
| US-20080181928-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES FOR LIPOSOME DELIVERY | LIPA, SGMS2, SGMS1 | ALDH1A1 4605/4885MEN1 748/4885KMT2A 2165/4885 |
| US-20040137050-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | LDLR, CETP, CYP11A1 | ALDH1A1 4598/4885MEN1 1487/4885KMT2A 2146/4885 |
| US-20070154447-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | LDLR, CETP, CYP11A1 | ALDH1A1 4598/4885MEN1 1487/4885KMT2A 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.